The role of Plasma Membrane Calcium ATPases (PMCAs) in neurodegenerative disorders
Neuroscience Letters, ISSN: 0304-3940, Vol: 663, Page: 29-38
2018
- 21Citations
- 47Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations21
- Citation Indexes21
- 21
- CrossRef18
- Captures47
- Readers47
- 47
- Mentions1
- News Mentions1
- News1
Most Recent News
The role of Plasma Membrane Calcium ATPases (PMCAs) in neurodegenerative disorders.
Neurosci Lett. 2018 Jan 10;663:29-38. Authors: Hajieva P, Baeken MW, Moosmann B PubMed: 29452613 Submit Comment
Review Description
Selective degeneration of differentiated neurons in the brain is the unifying feature of neurodegenerative disorders such as Parkinson’s disease (PD) or Alzheimer’s disease (AD). A broad spectrum of evidence indicates that initially subtle, but temporally early calcium dysregulation may be central to the selective neuronal vulnerability observed in these slowly progressing, chronic disorders. Moreover, it has long been evident that excitotoxicity and its major toxic effector mechanism, neuronal calcium overload, play a decisive role in the propagation of secondary neuronal death after acute brain injury from trauma or ischemia. Under physiological conditions, neuronal calcium homeostasis is maintained by a fine-tuned interplay between calcium influx and releasing mechanisms (Ca 2+ -channels), and calcium efflux mechanisms (Ca 2+ -pumps and -exchangers). Central functional components of the calcium efflux machinery are the Plasma Membrane Calcium ATPases (PMCAs), which represent high-affinity calcium pumps responsible for the ATP-dependent removal of calcium out of the cytosol. Beyond a growing body of experimental evidence, it is their high expression level, their independence of secondary ions or membrane potential, their profound redox regulation and autoregulation, their postsynaptic localization in close proximity to the primary mediators of pathological calcium influx, i.e. NMDA receptors, as well as evolutionary considerations which all suggest a pivotal role of the PMCAs in the etiology of neurodegeneration and make them equally challenging and alluring candidates for drug development. This review aims to summarize the recent literature on the role of PMCAs in the pathogenesis of neurodegenerative disorders.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0304394017307759; http://dx.doi.org/10.1016/j.neulet.2017.09.033; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85042023841&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/29452613; https://linkinghub.elsevier.com/retrieve/pii/S0304394017307759; https://dx.doi.org/10.1016/j.neulet.2017.09.033
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know